Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
At 100 μM Apoptosis Activator 2 exhibited 100% cytotoxicity in virtually all cell lines
Dirithromycin is a more lipid-soluble prodrug derivative of 9S-erythromycyclamine prepared by condensation of the latter with 2-(2-methoxyethoxy)acetaldehyde
InChi: InChI=1S/C27H32F2N8O/c1-4-35-7-9-36(10-8-35)15-18-5-6-23(30-13-18)32-27-31-14-21(29)25(34-27)19-11-20(28)26-22(12-19)37(17(2)3)24(16-38)33-26/h5-6
28)35-16-12-14-17(15-13-16)36(32
Oritavancin(LY-333328) 18655 At 100 μM Apoptosis ActivatorOritavancin is a novel semisynthetic glycopeptide antibiotics. On August 6, 2014, the FDA approved oritavancin for treatment of skin infections. Oritavancin possesses potent and rapid bactericidal activity in vitro against a broad spectrum of both resistant and susceptible Gram positive bacteria, including Staphylococcus aureus, MRSA, enterococci, and streptococci. Product information CAS Number: 171099 57 3 Molecular Weight: 1748. 06 Formula: